Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Early Tender Results of Cash Tender Offers
-
Novel combination including eftilagimod alfa (efti) in neoadjuvant setting drives 51.5% tumour hyalinization/fibrosis in patients with soft tissue sarcoma (p<0.001) High level of tumour...
-
Novel combination of efti with KEYTRUDA® and chemotherapy generates strong response rates across all PD-L1 expression levels in first line non-small cell lung cancer (1L NSCLC) including 61.7% ORR in...
-
Preliminary data from first three patients in Phase 2b imaging clinical trial of RAD 101 show uptake in brain metastases from solid tumors, confirming proof-of-concept with Phase 2 topline results...
-
RAD has received firm commitments for a A$35 million capital raising via an institutional private placement to new Australian and international institutional and sophisticated investors at A$0.03 per...
-
NEW YORK, Oct. 19, 2025 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided highlights of its...
-
Highlights: Das Kiniéro-Goldprojekt von Robex in Guinea verläuft weiterhin planmäßig und im Rahmen des Budgets für die erste Goldförderung im 4. Quartal 2025.Das Kiniéro-Projekt bleibt mit 4.857.704...
-
Points clés : Le projet aurifère Kiniéro de Robex, en Guinée, demeure dans les délais et le budget pour sa première coulée d’or au quatrième trimestre de l’année civile 2025. Le projet n’a...
-
Key Highlights Major macroeconomic and geopolitical shifts during the quarter are reshaping the Western mine-to-magnet industryThe Halleck Creek Rare Earths Project represents a long-term,...
-
PERTH, Australia, Oct. 16, 2025 (GLOBE NEWSWIRE) -- Paladin Energy Ltd (ASX:PDN, TSX:PDN, OTCQX:PALAF) (Paladin or the Company) advises its shareholders (Shareholders) that the Notice of Meeting and...